Should medications for pediatric bipolar disorder ever be reduced or stopped? This update reviews relapse risk after discontinuation, how bipolar I differs from bipolar II, and a stepwise approach to minimizing antipsychotic exposure—covering patient selection, taper pacing, and the role of adjunctive psychotherapy.